MDT

97.62

+2.1%↑

VEEV

295.33

-1.66%↓

A

141.88

+2.34%↑

HQY

88.54

-1.25%↓

PHR.US

23.21

+1.66%↑

MDT

97.62

+2.1%↑

VEEV

295.33

-1.66%↓

A

141.88

+2.34%↑

HQY

88.54

-1.25%↓

PHR.US

23.21

+1.66%↑

MDT

97.62

+2.1%↑

VEEV

295.33

-1.66%↓

A

141.88

+2.34%↑

HQY

88.54

-1.25%↓

PHR.US

23.21

+1.66%↑

MDT

97.62

+2.1%↑

VEEV

295.33

-1.66%↓

A

141.88

+2.34%↑

HQY

88.54

-1.25%↓

PHR.US

23.21

+1.66%↑

MDT

97.62

+2.1%↑

VEEV

295.33

-1.66%↓

A

141.88

+2.34%↑

HQY

88.54

-1.25%↓

PHR.US

23.21

+1.66%↑

Search

Pacific Biosciences of California Inc

Fechado

SetorSaúde

1.49 4.93

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.42

Máximo

1.52

Indicadores-chave

By Trading Economics

Rendimento

384M

-42M

Vendas

2.6M

40M

Margem de lucro

-105.442

Funcionários

575

EBITDA

367M

-36M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+39.16% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-42M

375M

Abertura anterior

-3.44

Fecho anterior

1.49

Sentimento de Notícias

By Acuity

38%

62%

116 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Pacific Biosciences of California Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de out. de 2025, 14:47 UTC

Grandes Movimentos do Mercado

Esperion Therapeutics Shares Rise After Blocking Generic Version of Cholesterol Drug

3 de out. de 2025, 14:25 UTC

Grandes Movimentos do Mercado

Shopify Shares Rise as TD Cowen Raises Price Target

3 de out. de 2025, 13:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Anglo American Initiates Arbitration Proceedings After Peabody Deal Falls Through

3 de out. de 2025, 12:40 UTC

Grandes Movimentos do Mercado

Alto Neuroscience Shares Rise After Getting FDA Fast-Track Designation

3 de out. de 2025, 22:02 UTC

Aquisições, Fusões, Aquisições de Empresas

First National Financial Gets Ontario Court Approval for Sale to Birch Hill Equity and Brookfield

3 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

3 de out. de 2025, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

3 de out. de 2025, 19:56 UTC

Conversa de Mercado

Treasury Yields Have Weekly Loss as Key Statistics Go Unseen -- Market Talk

3 de out. de 2025, 19:52 UTC

Aquisições, Fusões, Aquisições de Empresas

This Mini-Berkshire Insurer Looks Cheap After Sale Of California Unit At High Price -- Barrons.com

3 de out. de 2025, 19:21 UTC

Conversa de Mercado

Crude Prices End Week Lower Ahead of OPEC Meeting -- Market Talk

3 de out. de 2025, 19:05 UTC

Conversa de Mercado

Natural-Gas Futures Face Mild Temperatures -- Market Talk

3 de out. de 2025, 19:04 UTC

Aquisições, Fusões, Aquisições de Empresas

BlackRock Group Hunts a $20 billion Deal to Get In on the AI Boom -- WSJ

3 de out. de 2025, 18:22 UTC

Conversa de Mercado

Bank of Canada Tentative About More Rate Cuts Due to Upside CPI Risks -- Market Talk

3 de out. de 2025, 17:15 UTC

Conversa de Mercado

U.S. Oil Rig Count Decreased Last Week -- Market Talk

3 de out. de 2025, 16:26 UTC

Conversa de Mercado

Long-Term Treasury Yields Expected to Shrug Off Fed Cut -- Market Talk

3 de out. de 2025, 16:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

3 de out. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

3 de out. de 2025, 16:16 UTC

Conversa de Mercado

Alaska Air, American Airlines Expected to Post Disappointing 3Q Results -- Market Talk

3 de out. de 2025, 16:02 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de out. de 2025, 16:02 UTC

Conversa de Mercado

Airline Industry Bifurcation Likely to Define 3Q Earnings -- Market Talk

3 de out. de 2025, 15:17 UTC

Aquisições, Fusões, Aquisições de Empresas

Tech Buyouts Have Heated Up. These 8 Companies Could Be Next. -- Barrons.com

3 de out. de 2025, 14:56 UTC

Conversa de Mercado

European Credit Spreads Could Tighten as New Supply Stays Low -- Market Talk

3 de out. de 2025, 14:10 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de out. de 2025, 14:10 UTC

Conversa de Mercado

Sanofi Sales Could Miss Forecasts, With Adjusted Profit in Line -- Market Talk

3 de out. de 2025, 13:34 UTC

Conversa de Mercado

Natural Gas Futures Down Amid High Supply, Mild Demand -- Market Talk

3 de out. de 2025, 13:29 UTC

Conversa de Mercado

Crude Prices Rise Slightly Ahead of OPEC+ Meeting -- Market Talk

3 de out. de 2025, 13:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

3 de out. de 2025, 13:14 UTC

Conversa de Mercado

Brazilian Companies Face Higher Financing Costs, Fitch Says -- Market Talk

3 de out. de 2025, 13:10 UTC

Conversa de Mercado

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

3 de out. de 2025, 12:52 UTC

Conversa de Mercado

Ferrari Results Secondary to Investor Day -- Market Talk

Comparação entre Pares

Variação de preço

Pacific Biosciences of California Inc Previsão

Preço-alvo

By TipRanks

39.16% parte superior

Previsão para 12 meses

Média 1.99 USD  39.16%

Máximo 3 USD

Mínimo 1.25 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Pacific Biosciences of California Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

3

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.13 / N/ASuporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

116 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
help-icon Live chat